PEPTIDE RESEARCH TOPIC

Kisspeptin-10 Research Peptide

Kisspeptin-10 is a short kisspeptin fragment studied in reproductive hormone signaling. Browse receptor biology, human endocrine experiments, and research limitations.

TOPIC OVERVIEW

About Kisspeptin-10

Identity and names

Kisspeptin-10 is the ten-amino-acid fragment commonly abbreviated KP-10. Studies of Kisspeptin-54 should not be silently relabeled as KP-10 studies.

Compound type

It belongs to the kisspeptin peptide family. Related fragments share receptor biology but can differ in exposure and pharmacokinetics.

Mechanism

Kisspeptin activates KISS1R and influences GnRH-linked reproductive hormone signaling. Hormone responses vary with biological setting.

Research focus and evidence

Small human studies measured LH and other hormones, including differences by sex and menstrual phase. Acute endocrine responses do not establish a general fertility treatment.

Regulatory status and limits

Research preparation and route remain important. Experimental hormone changes cannot validate self-administered protocols or establish product authorization.

Topics covered
  • KISS1R and GnRH
  • KP-10 versus KP-54
  • LH and FSH measurements
  • sex and menstrual-phase effects
  • human experimental evidence
Common names and related terms: Kisspeptin-10, Kisspeptin 10, KP-10
RESEARCH SUMMARY

What Is Kisspeptin-10?

LAST VERIFIEDOctober 7, 2026

An early human experiment found that Kisspeptin-10 stimulated LH secretion in men and examined pulsatile hormone responses. This is direct endocrine evidence, but its small experimental cohorts do not define routine treatment. KP-10 hormone study in men

A separate human study found that responses differed between men and women and by menstrual-cycle phase. This context is essential when interpreting broad claims that kisspeptin uniformly increases reproductive hormones. KP-10 study of sex differences

EVIDENCE PROFILE

Kisspeptin-10 Research Evidence

A concise view of registered clinical research, PubMed-indexed literature, evidence stage, and important limitations.

LAST VERIFIEDOctober 7, 2026
Registered records5
Active studies0
Completed studies3
PubMed records316
Compound typeIt belongs to the kisspeptin peptide family. Related fragments share receptor biology but can differ in exposure and pharmacokinetics.
AliasesKisspeptin-10, Kisspeptin 10, KP-10
Evidence stageSmall human studies measured LH and other hormones, including differences by sex and menstrual phase. Acute endocrine responses do not establish a general fertility treatment.
U.S. regulatory contextResearch preparation and route remain important. Experimental hormone changes cannot validate self-administered protocols or establish product authorization.
CLINICAL REGISTRY

Selected registered research

NCT03771326Phase 3 · Completed

KP-10 and Insulin Secretion in Men

NCT03315325Phase 3 · Completed

Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men

NCT03286517Phase 3 · Completed

Link Between the Sensitivity of Kisspeptin Signalling and Pubertal Onset in Boys.

INDEXED LITERATURE

Selected PubMed records

PMID 216328072011 Aug · The Journal of clinical endocrinology and metabolism

Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.

PMID 219767242011 Dec · The Journal of clinical endocrinology and metabolism

The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans.

PMID 389781712024 Sep · Biomedical chromatography : BMC

Investigating the detection of the novel doping‐relevant peptide kisspeptin‐10 in urine using liquid chromatography high‐resolution mass spectrometry.

How to interpret this profile

Registry and publication counts describe discoverable records, not proof of effectiveness or safety. Study design, compound identity, population, endpoints, and regulatory context must be reviewed individually.

Primary sources: ClinicalTrials.gov (defined search) · PubMed (defined query)Checked October 7, 2026. Counts include interventional registry records with an explicit matching intervention name or alias; broad search results, biomarker-only observations, and unrelated compounds are excluded. Active includes recruiting, not yet recruiting, active not recruiting, and enrolling by invitation. PubMed is the linked title/abstract query count, not a number of clinical trials or a measure of evidence quality.

Displayed records are selected for relevance and recency; the page does not reproduce the complete source databases.

START HERE

Essential Kisspeptin-10 guides

KISSPEPTIN-10 KNOWLEDGE ARTICLESPage 1 of 3
07
KNOWLEDGE ARTICLE

Kisspeptin-10 Side Effects: What Research Shows

Kisspeptin-10 side effects are usually mild — headache, nausea, flushing, and injection-site reactions. Learn what research and user reports actually show.

↗
08
KNOWLEDGE ARTICLE

Kisspeptin Peptide: What It Is and How It Works

Kisspeptin peptide is a research neuropeptide that triggers GnRH and reproductive hormones. Learn how it works, forms, dosing, legal status, and safety.

↗
09
KNOWLEDGE ARTICLE

Kisspeptin-10 Reviews: What Users Report

Kisspeptin-10 reviews reveal mixed results, dosing details, and safety concerns. Read what users say about fertility, side effects, and research use.

↗
11
KNOWLEDGE ARTICLE

Kisspeptin-10 How to Use: Research Mixing Guide

Kisspeptin-10 how to use involves reconstitution with bacteriostatic water and subcutaneous injection in research settings. Learn typical protocols and safety notes.

↗
19
KNOWLEDGE ARTICLE

Kisspeptin in Food: What You Need to Know

Kisspeptin in food is a common search, but no food contains this peptide hormone. Learn how diet affects kisspeptin, estrogen, and reproductive health.

↗